A phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in patients with HER2-high and HER2-low gastric or gastroesophageal junction (GEJ) adenocarcinoma Meeting Abstract
| Authors: | Ku, G.; Piha-Paul, S.; Gupta, M.; Oh, D.; Kim, Y.; Lee, J.; Rha, S.; Kang, Y.; Diez García, M.; Fleitas Kanonnikoff, T.; Arrazubi, V.; Aviano, K.; Demuth, T. |
| Abstract Title: | A phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in patients with HER2-high and HER2-low gastric or gastroesophageal junction (GEJ) adenocarcinoma |
| Meeting Title: | ESMO 24th World Congress on Gastrointestinal Cancer 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2022 Jun 29-Jul 2 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-06-01 |
| Start Page: | S265 |
| Language: | English |
| ACCESSION: | WOS:000823826500066 |
| DOI: | 10.1016/j.annonc.2022.04.143 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P-53 -- Source: Wos |
